| 发明名称 |
PHARMACEUTICAL COMBINATION FORMULATION |
| 摘要 |
<p>A solid oral dosage form comprising diltiazem (or a pharmaceutically acceptable salt thereof) in controlled release form and hydrochlorothiazide in normal release form. Preferably the controlled release component comprises a plurality of spheroids comprising diltiazem and a spheronising agent.</p> |
| 申请公布号 |
IL102777(D0) |
申请公布日期 |
1993.01.31 |
| 申请号 |
IL19920102777 |
申请日期 |
1992.08.10 |
| 申请人 |
EUROCELTIQUE S.A. |
发明人 |
|
| 分类号 |
A61K9/50;A61K9/52;A61K31/54;A61K31/55;A61K47/36;A61P9/12;(IPC1-7):A61K/ |
主分类号 |
A61K9/50 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
